Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

As 2026 gets underway, we look at what lies ahead in terms of changes to tax rates and allowances this year and how it will ...

During proceedings in the Telangana Legislative Council, Kavitha grew emotional while responding to questions on her rift ...

Parliament has cleared the SHANTI Bill, opening India’s State-controlled nuclear power sector to private and foreign ...

The New Year can be an opportunity to reset. For owner-managed businesses in Northern Ireland taking control of tax and ...

I was solidly against the idea of skinny jabs. Like a censorious old bat I ­complained about the very idea of losing weight ­without effort.

The White House said Tuesday that President Donald Trump is “discussing a range of options” to acquire Greenland, making ...

Scientists are racing to rescue hundreds of datasets, websites and federal reports that have been deleted by the ...

Thousands have reclaimed health through this structured path, and Marchman Act Addiction Treatment stands as one respected guide in the field ...

After months of being turned away from emergency rooms and reaching out to local and provincial politicians, Kim Johnston ...

The fetish of automation masks the commodification of combat judgment. Corporate software reshapes war while preserving just ...